In re: Entresto (Sacubitril/Valsartan)
| NOVARTIS PHARMACEUTICALS CORPORATION |
| TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS INC., HETERO USA, INC., HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-III, MSN PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD. and MSN LIFE SCIENCES PRIVATE LTD. |
| 23-2218 |
| July 31, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Opinions
We have the following opinions for this case:
| Description |
|---|
| IN RE: ENTRESTO (SACUBITRIL/VALSARTAN) |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 24, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 16
ORDER granting the motions [ # 15 ] [ # 943725-2 ] to the extent that the appeals are consolidated, and thus one set of briefs should be filed for the five appeals. The revised official caption is reflected above. Appellant's opening brief is due no later than October 10, 2023. Absent objection within seven days from the date of entry of this order, the court will revise the official caption to reflect Alembic's non-participation in these appeals. Service as of this date by the Clerk of Court. [945715] [23-2218, 23-2219, 23-2220, 23-2221, 23-2260] [LMS] [Entered: 08/24/2023 03:12 PM]
|
| Filing 15 MOTION of Appellant Novartis Pharmaceuticals Corporation to consolidate appeals (23-2218, 23-2219, 23-2220, 23-2221, and 23-2260). Service: 08/16/2023 by email. [943720] [23-2218] [Deanne Maynard] [Entered: 08/16/2023 05:34 PM] |
| Filing 14 Notice of Related Case Information for Appellant Novartis Pharmaceuticals Corporation. Service: 08/14/2023 by email. [942926] [23-2218] [Deanne Maynard] [Entered: 08/14/2023 05:40 PM] |
| Filing 13 Docketing Statement for the Appellant Novartis Pharmaceuticals Corporation. Service: 08/14/2023 by email. [942925] [23-2218] [Deanne Maynard] [Entered: 08/14/2023 05:37 PM] |
| Filing 12 Certificate of Interest for Appellant Novartis Pharmaceuticals Corporation. Service: 08/14/2023 by email. [942923] [23-2218] [Deanne Maynard] [Entered: 08/14/2023 05:34 PM] |
| Filing 11 Entry of Appearance for Nicholas N. Kallas; Christina Schwarz as counsel for Appellant Novartis Pharmaceuticals Corporation. Service: 08/14/2023 by email. [942917] [23-2218] [Deanne Maynard] [Entered: 08/14/2023 05:28 PM] |
| Filing 10 Notice of Related Case Information for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 08/14/2023 by email. [942795] [23-2218] [Ronald Daignault] [Entered: 08/14/2023 01:53 PM] |
| Filing 9 Docketing Statement for the Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 08/14/2023 by email. [942794] [23-2218] [Ronald Daignault] [Entered: 08/14/2023 01:51 PM] |
| Filing 8 Certificate of Interest for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 08/14/2023 by email. [942790] [23-2218] [Ronald Daignault] [Entered: 08/14/2023 01:50 PM] |
| Filing 7 Entry of Appearance for Ronald M. Daignault; Richard Juang as counsel for Appellees MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc.. Service: 08/14/2023 by email. [942788] [23-2218] [Ronald Daignault] [Entered: 08/14/2023 01:47 PM] |
| Filing 6 Notice of Related Case Information for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA, Inc., Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 08/14/2023 by email. [942780] [23-2218] [Dmitry Shelhoff] [Entered: 08/14/2023 01:37 PM] |
| Filing 5 Docketing Statement for the Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA, Inc., Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 08/14/2023 by email. [942779] [23-2218] [Dmitry Shelhoff] [Entered: 08/14/2023 01:36 PM] |
| Filing 4 Certificate of Interest for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA, Inc., Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 08/14/2023 by email. [942778] [23-2218] [Dmitry Shelhoff] [Entered: 08/14/2023 01:34 PM] |
| Filing 3 Entry of Appearance for Dmitry V. Shelhoff; Kenneth S. Canfield; Edward D. Pergament; Julia S. Kim as counsel for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA, Inc., Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 08/14/2023 by email. [942777] [23-2218] [Dmitry Shelhoff] [Entered: 08/14/2023 01:32 PM] |
| Filing 2 Entry of Appearance for Deanne E. Maynard; Seth W. Lloyd as counsel for Appellant Novartis Pharmaceuticals Corporation. Service: 08/02/2023 by email. [940085] [23-2218] [Deanne Maynard] [Entered: 08/02/2023 11:49 AM] |
| Filing 1 Appeal docketed. Received: 07/25/2023. [939660] Entry of Appearance due 08/14/2023. Certificate of Interest is due on 08/14/2023. Docketing Statement due 08/14/2023. Appellant's brief is due 09/29/2023. [MMA] [Entered: 07/31/2023 05:39 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
